Suggestions
Lindsay Klee
Intent Venture Management, Intent Capital - Commercialization/Medical/Healthcare Investment Professional & Michigan SBDC
Lindsay Klee is the Founder and Managing Partner at Intent Capital and the Intent Impact Fund, where she focuses on advancing healthcare innovations and addressing disparities in brain health. Her work primarily involves advising investors, research and development teams, and healthcare clients across the United States, with a particular emphasis on technologies that improve care in brain health domains.3
Professional Background
Klee has a robust background in technology commercialization and healthcare consulting. She began her career at Pfizer Global Research and Development, where she worked on drug discovery related to multidrug-resistant microorganisms. This experience sparked her interest in accelerating the innovation and commercialization processes within healthcare.12
She has held significant roles in various institutions, including:
- Senior Director of Technology Commercialization at Wayne State University, where she led initiatives to promote entrepreneurial culture and support startup ventures.1
- Commercialization Director at the University of Michigan Medical Innovation Center, where she was instrumental in managing a gap fund for product development in healthcare technologies.1
Klee's expertise extends to regulatory strategies, reimbursement frameworks, and operational solutions for medical devices and diagnostics. She has also consulted for venture capital investors and health care institutions, enhancing her understanding of the intersection between technology development and market needs.23
Education and Skills
Klee holds a master's degree in healthcare management and has studied public and private finance. Her skill set includes:
- Multi-functional team leadership
- Technology revenue growth strategies
- Regulatory compliance
- Financial management
- Deal structuring and M&A strategies.23
Impact and Vision
Through Intent Capital and the Intent Impact Fund, Klee aims to eliminate inequities in prevention, diagnosis, and treatment within brain health. Her initiatives are designed to support diverse entrepreneurs, particularly female founders who often face challenges in securing funding compared to their male counterparts. Klee's commitment is to catalyze economic returns while enhancing patient welfare across various healthcare sectors.3
In summary, Lindsay Klee is a prominent figure in the healthcare innovation landscape, leveraging her extensive experience to drive meaningful change in brain health care through strategic investment and commercialization efforts.
Highlights
Within my own family, I've witnessed restrictions and yet also tremendous benefits from remote/telehealth care. ⚕ 🤯 How does the U.S. best decide which remote care / tele-health technology to pay for, reimburse and/or to provide? 💵 💲 This article provides a terrific overview of recent (April 10, 2024) House Energy & Commerce Committee Considerations.
Many medtech/life science companies, tech innovators, clinical professionals and investors are looking to integrate with remote and/or cross-state border care approaches. Did you know that at least 42 million Americans lack access to terrestrial broadband internet? That state of licensure can impact or negate telehealth reimbursement for providers? That some technologies FDA cleared or approved for at-home use may not be paid-for/reimbursed for at-home use? Potential reimbursement & healthcare system impacts of telehealth, remote patient monitoring and out-of-state care are important to consider. Looking to customize your commercial technology development and revenue planning to gain appropriate insurer/payor or regulatory buy-in? Drop me a note!
The House Energy and Commerce Committee recently conducted a hearing to discuss legislative proposals that aim to support patient access to telehealth. During the hearing, patient advocate Jeanette Ashlock shared her experience with multiple sclerosis (MS) and how telehealth has become an essential tool for her to access care. Her testimony highlights the ongoing need for telehealth-based care models and the potential pitfalls of expanded access to the care modality. #IntentVentureManagement https://lnkd.in/gRuk-n2m
Read the full article here: https://lnkd.in/gEkQnJEZ.
